Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT04754191 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04754191
- Sponsor
- University of Utah
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-05
- Primary completion
- 2025-04-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.